期刊文献+

老年人慢性左心力衰竭严重程度与循环内皮细胞微颗粒CD31^+水平变化的关系

The relationship between degrees of chronic left heart failure and changes of circulating endothelial microparticle CD31^+ in elderly patients
下载PDF
导出
摘要 目的探讨外周血循环内皮细胞微颗粒CD31^+水平变化与老年人慢性左心力衰竭严重程度的相关性。方法根据纽约心功能分级(NYHA)和左心室射血分数(LVEF)将老年慢性左心力衰竭患者分成Ⅰ级、Ⅱ级、Ⅲ级和Ⅳ级组,并纳入同期健康老年人30名作为对照组。采用流式细胞仪检测健康对照者和老年慢性左心力衰竭患者CD31^+的表达。结果随着NYHA的升高和LVEF的下降,CD31^+的水平明显上升(P<0.01)[对照组(348±42)个/μl;Ⅰ级组(478±40)个/μl;Ⅱ级组(659±42)个/μl;Ⅲ级组(846±43)个/μl;Ⅳ级组(1596±46)个/μl,均为P<0.01]。结论 CD31^+表达显著上调可能参与了老年人慢性左心力衰竭发生发展。 Objective To study the relationship between expression of circulating endothelial microparticle CD31+ ( CD31+ )of peripheral blood and degrees of chronic left heart failure in elderly patients. Methods According to New York Heart Association (NYHA)class, the patients were divided to four groups: class Ⅰ , class Ⅱ, classⅢ and class Ⅳ, and 30,healthy subjects were as controls. The expression of circulating CD31+ of the patients and healthy subjects was measured by flow cytometry. Results The levels of circulating CD31+ were increased significantly with severe chronic left heart failure in elderly patients [ control( 348 ±42)cell/μl; class Ⅰ(478 ±40)cell/μl;class Ⅱ (659 ±42)eell/μl;class Ⅲ(846±43)cell/μl;class Ⅳ(1596 ±46)cell/μl,all P 〈0.05]. Conclusion The upregulation of circulating CD31 + may contribute to the development of chronic heart failure in elderly.
出处 《中国心血管杂志》 2011年第2期112-114,共3页 Chinese Journal of Cardiovascular Medicine
基金 江苏省淮安市科技局科技项目(HAS 04020)
关键词 老年人 心力衰竭 充血性 内皮细胞 流式细胞术 Aged Heart failure, congestive Endothelial ceils Flow cytometry
  • 相关文献

参考文献9

  • 1Ahmed A. DEFEAT heart failure : clinical manifestations, diagnostic assessment, and etiology of geriatric heart failure. Heart Fail Clin, 2007, 3:389-402.
  • 2JungKH, Chu K, Lee ST, et al. Circulating endothelial microparticles as a marker of cerebrovascular disease. Ann Neurol, 2009, 66 : 191-199.
  • 3Gimelli A,Landi P, Marraceini P, et al. Left ventricular ejection fraction measurements: accuracy and prognostic implications in a large population of patients with known or suspected ischemic heart disease, lnt J Cardiovasc Imaging, 2008, 24:793-801.
  • 4Werner N,Wassmann S, Ahlers P, et al. Circulating CD31^+/ annexin Vapoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol, 2006,26 : 112-116.
  • 5Chong AY,Blann AD, Patel J, et al. Endothelial dysfunction and damage in congestive heart failure : relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation, 2004,110 : 1794-1798.
  • 6Bernal-Mizrachi L, Jy W, Fierro C, et al. Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol, 2004,97:439-446.
  • 7Nourshargh S,Krombach F, Dejana E. The role of JAM-A and PECAM-I in modulating leukocyte infiltration in inflamed and ischemic tissues. J Leukoc Bio1,2006 ,80 :714-718.
  • 8Heitzer T, Baldus S, yon Kodolitsch Y, et al. Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure. Arterioscler Thromb Vasc Biol, 2005,25 : 1174- 1179.
  • 9de Berrazueta JR, Guerra-Ruiz A, Garcia-Unzueta MT, et al. Endothelial dysfunction, measured by reactive hyperaemia using strain-gauge plethysmography, is an independent predictor of adverse outcome in heart failure. Eur J Heart Failure, 2010,5: 477-483.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部